The authors discuss the technology and guidance required to achieve good KM in a biopharmaceutical company.
This article presents first-hand perspectives from industry users to suppliers of single-use sensors.
This article presents first-hand perspectives from industry users to suppliers of single-use sensors.
This article presents first-hand perspectives from industry users to suppliers of single-use sensors.
This article presents first-hand perspectives from industry users to suppliers of single-use sensors.
This article presents first-hand perspectives from industry users to suppliers of single-use sensors.
This article presents first-hand perspectives from industry users to suppliers of single-use sensors.
This article presents first-hand perspectives from industry users to suppliers of single-use sensors.
This article presents first-hand perspectives from industry users to suppliers of single-use sensors.
This article presents first-hand perspectives from industry users to suppliers of single-use sensors.
This article presents first-hand perspectives from industry users to suppliers of single-use sensors.
Solutions are emerging to manage advanced modalities and evolving regulatory requirements for viral clearance.
Industry players form Allotrope Foundation to solve analytical data management problems.
Industry players form Allotrope Foundation to solve analytical data management problems.
Choosing the optimal protein expression vector depends on strain, promoter, and a number of other factors.
Choosing the optimal protein expression vector depends on strain, promoter, and a number of other factors.
Choosing the optimal protein expression vector depends on strain, promoter, and a number of other factors.
Manufacturer supply chain needs are changing in response to widening product temperature ranges.
Development and validation of two pivotal assays for in-vitro comparability testing of insulin biosimilars.
Development and validation of two pivotal assays for in-vitro comparability testing of insulin biosimilars.
Development and validation of two pivotal assays for in-vitro comparability testing of insulin biosimilars.
This article reviews the definition of HCPs, risks posed by HCPs, regulatory concerns, commonly accepted ELISA methods for HCP measurement and their limitations, and orthogonal methods available for HCP characterization.